OncoSec Medical, Inc. is a biotechnology company focused on designing, developing and commercializing therapies and proprietary medical approaches to stimulate and to guide an anti-tumor immune response for the treatment of cancer. Its lead product candidate, ImmunoPulse IL-12, uses an electroporation device, with the aim of reversing the immunosuppressive microenvironment in the treated tumor. The company was founded by Avtar S. Dhillon and Punit S. Dhillon on February 8, 2008 and is headquartered in Ewing, NJ.
Sector:
Health Services
Industry:
Medical Or Nursing Services
Employees:
N/A
Frequently Asked Questions
What is Market Cap of OncoSec Medical Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. OncoSec Medical Inc market cap is $0.00.
What is the 52-week high for OncoSec Medical Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. OncoSec Medical Inc 52 week high is $0.0423 as of October 10, 2025.
What is the 52-week low for OncoSec Medical Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. OncoSec Medical Inc 52 week low is $0.00 as of October 10, 2025.
What is the 50-day moving average of OncoSec Medical Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. OncoSec Medical Inc 50-day moving average is $0.00.